DOD Biotech PCL (BKK:DOD-R) EV-to-Revenue : 1.03 (As of Jul. 24, 2025)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, DOD Biotech PCL's enterprise value is ฿669.6 Mil. DOD Biotech PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ฿648.1 Mil. Therefore, DOD Biotech PCL's EV-to-Revenue for today is 1.03.

The historical rank and industry rank for DOD Biotech PCL's EV-to-Revenue or its related term are showing as below:

BKK:DOD-R' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.55 Med: 3.61 Max: 12.56
Current: 1.04

During the past 11 years, the highest EV-to-Revenue of DOD Biotech PCL was 12.56. The lowest was 0.55. And the median was 3.61.

BKK:DOD-R's EV-to-Revenue is ranked better than
55.36% of 1904 companies
in the Consumer Packaged Goods industry
Industry Median: 1.2 vs BKK:DOD-R: 1.04

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-24), DOD Biotech PCL's stock price is ฿1.96017. DOD Biotech PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ฿1.44. Therefore, DOD Biotech PCL's PS Ratio for today is 1.36.

DOD Biotech PCL EV-to-Revenue Historical Data

The historical data trend for DOD Biotech PCL's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL EV-to-Revenue Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

3.42

4.53

3.71

2.70

0.87

DOD Biotech PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															1.97	1.28	1.89	0.87	0.59

Competitive Comparison of DOD Biotech PCL's EV-to-Revenue

For the Packaged Foods subindustry, DOD Biotech PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DOD Biotech PCL's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

DOD Biotech PCL EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

DOD Biotech PCL's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	669.595	/	648.13
	=	1.03

DOD Biotech PCL's current Enterprise Value is ฿669.6 Mil.
DOD Biotech PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿648.1 Mil.

DOD Biotech PCL (BKK:DOD-R) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

DOD Biotech PCL's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.96017	/	1.439
	=	1.36

DOD Biotech PCL's share price for today is ฿1.96017.
DOD Biotech PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1.44.

DOD Biotech PCL EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines